SYN1 and synucleinopathy: Together, these data demonstrate that A30P-aSyn-O can disrupt neuronal synapses by the activation of NFAT signaling pathway and subsequent downregulation of Syn1 expression suggesting NFAT pathway inhibition might be a target for pharmacological modulation in synucleinopathies.